Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 31.16 | N/A |
PEG Ratio (TTM) | 1.09 | N/A |
P/S Ratio (TTM) | 1.80 | N/A |
P/B Ratio (TTM) | 1.74 | N/A |
P/FCF Ratio (TTM) | -369.30 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.99% | N/A |
ROE (TTM) | 6.02% | N/A |
Net Profit Margin (TTM) | 5.67% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 71.97% | -452.80% | N/A |
Revenue | 4.50% | -0.83% | N/A |
Net Income | 73.67% | -462.35% | N/A |
Cash Flow | 15.21% | -13.64% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.59 | N/A |
Quick Ratio (TTM) | 0.46 | N/A |
D/E Ratio (TTM) | 0.64 | N/A |
Interest Coverage (TTM) | 2.23 | N/A |
Piotroski F-Score | 6 | N/A |
Altman Z-Score | 0.97 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |